AKT1 and neoplasm: Mechanistically, Rab39a acts as a potential tumor suppressor via significantly decreasing phosphorylation levels of AKT at Ser473, and its inhibition effects could be blocked by using AKT pathway inhibitor (Zou et al. 2019).